<code id='0D6170DF76'></code><style id='0D6170DF76'></style>
    • <acronym id='0D6170DF76'></acronym>
      <center id='0D6170DF76'><center id='0D6170DF76'><tfoot id='0D6170DF76'></tfoot></center><abbr id='0D6170DF76'><dir id='0D6170DF76'><tfoot id='0D6170DF76'></tfoot><noframes id='0D6170DF76'>

    • <optgroup id='0D6170DF76'><strike id='0D6170DF76'><sup id='0D6170DF76'></sup></strike><code id='0D6170DF76'></code></optgroup>
        1. <b id='0D6170DF76'><label id='0D6170DF76'><select id='0D6170DF76'><dt id='0D6170DF76'><span id='0D6170DF76'></span></dt></select></label></b><u id='0D6170DF76'></u>
          <i id='0D6170DF76'><strike id='0D6170DF76'><tt id='0D6170DF76'><pre id='0D6170DF76'></pre></tt></strike></i>

          Home / Wikipedia / hotspot

          hotspot


          hotspot

          author:fashion    Page View:59728
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In